Healthcare
AI in pharma market to hit $28.6b by 2034 on drug discovery push
AI in pharma market to hit $28.6b by 2034 on drug discovery push
Asia Pacific is set to post the fastest growth.
1 hour ago
Gene editing market may nearly triple to $30.5b by 2033
Asia Pacific is seen as fastest-growing region.
21 hours ago
Biologics boom pushes biopharma equipment market toward $116.4b
Asia-Pacific is emerging as the fastest-growing region.
22 hours ago
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
1 day ago
India rolls out terminology, drug registry
The terminology service will be set up for consistent interpretation and exchange of health data.
2 days ago
AI-powered microscopy software poised for $3.09b surge by 2031
North America accounted for the largest market share in 2025.
2 days ago
China’s healthcare defies Hang Seng slump with 0.9% gain
Investor sentiment, however, weakened during the second quarter.
2 days ago
Abu Dhabi and MIT Koch advance AI-driven cancer research
It includes physician-scientist fellowships.
2 days ago
Biomarkers market to top $112b by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025.
2 days ago
AU’s Royal North Shore expands cancer trials access with new unit
It was funded by a $13.8m (AU$20m) gift.
3 days ago
Taiwan's NTUH, EVA Air launch in-flight doctor programme
Physicians recommend scheduling a consultation four to six weeks before departure.
3 days ago
Singapore's CGH cuts desflurane, slashes emissions
Desflurane usage fell to just 1.44 litres in 2025 from 242 litres in 2019.
3 days ago
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Hong Kong’s listing pathways provide issuers with flexibility and access to a sophisticated investor base.
3 days ago
Seoul St. Mary's Hospital, Dankook University centres team up on health tech prototypes
They will reduce prototyping time and costs.
3 days ago
Indonesia anchors Longevity 5.0 amidst regional stem cell gaps
Borderless Healthcare links regenerative medicine with clinics, resorts, and home-based wellness.
5 days ago
RESILIA valves reshape lifetime care planning
Durability data and transcatheter reintervention options are influencing treatment decisions across Asia-Pacific
5 days ago
Tissue valve uptake hinges on data and diagnosis
Durability evidence is shifting younger patient use whilst awareness remains Australia’s main adoption barrier.
5 days ago
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. How can healthcare providers make AI pay off?Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential